Notes from the lab: The IPST blog
The IPST blog is about the wonders and challenges we encounter every day in the drug development world. Beware of our ambitions: the IPST blog is entertaining, relatable, and not exactly the hinge on which history will turn.
Hence, it's purposefully limited to a 5 minute read.
Go ahead: Take a break, pick a topic, and if you disagree with us, comment and crash our party!
2023-02 Episode 1. De-risking an asset
A strategy for companies eager to de-risk early-development pharmaceutical programs.
2023-04 Episode 2. Omics
A primer in the emerging fields of proteomics, metabolomics, and lipidomics.
2023-06 Episode 3. Translation
Approaches we can all take to maximize our chances of success in drug development.
2023-08 Episode 4. Bleomycin: It's personal
The dual edges of a successful cancer therapeutics.
2023-10 Episode 5. Artificial Intelligence
The pros and cons of using ChatGPT in nonclinical drug development.
2024-01 Episode 6. A strategy to develop a cardiac anti-arrhythmic drug from scratch
Not very exciting that one, but one of the most useful episodes here, say the readers.
2024-03 Episode 7. A scientist’s social contract
Dan Quixote moment: IPST drops the gloves against the Scripps Institute.
2024-05 Episode 8. Custom science in an era of personalized medicine
Does it really cost more to run "good" science? Considering time, resources, etc? Probably not.
2024-07 Episode 9. Innovation
A heartfelt love letter to our latest crush: oligonucleotides.
2024-09 Episode 10. Ageing
Getting old isn't easy: This Episode presented to you IN LARGE FONTS for your convenience.
2025-4 Episode 11. Opportunity in opposition
With US political support for science eroding, inventors must adopt new ways to succeed.
2025-08 Episode 12. Heart failure then and now
There are 50 ways to leave your lover, a million ways to die in the West, and 20-some ways to model heart failure, it seems.